| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3790 |
| Trial ID | NCT06297408 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Axi-Cel|Relma-cel|Axicabtagene Ciloleucel|JWCAR029|relmacabtagene autoleucel|Yescarta |
| Location approved | China |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus Single Arm Phase I and Phase II Randomized Controlled Open, Multicenter Study |
| Year | 2024 |
| Country | China |
| Company sponsor | Shanghai Ming Ju Biotechnology Co., Ltd. |
| Other ID(s) | JWCAR029115 |
| Cohort 1 | |||||||
|
|||||||